Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.

NCT01534936 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01534936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01534936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2012
Enrollment
2,153 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

affective symptoms, schizophrenia